Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL

By Proactive Investors / December 28, 2023 / www.youtube.com / Article Link

Tonix Pharmaceuticals CEO Dr. Seth Lederman recently recently shared groundbreaking news during an interview with Steve ...

Recent News

Metals far outpacing tech over past year

February 09, 2026 / www.canadianminingreport.com

Gold stocks gain on metal recovery

February 09, 2026 / www.canadianminingreport.com

Immediate trigger for crash was new Fed Chairman pick

February 02, 2026 / www.canadianminingreport.com

Gold stocks slump on metal price decline

February 02, 2026 / www.canadianminingreport.com

Is the gold market starting to turn 'irrationally exuberant'?

January 26, 2026 / www.canadianminingreport.com

See all >